Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (141-150 of 1,725) with videos related to

Pageof 173
Sort By:
Rheumatic Diseases Clinics of North America|March 1, 2006
The definition and measurement of disease modification in inflammatory rheumatic diseasesDaniel Aletaha, Josef S Smolen
Nature Clinical Practice. Rheumatology|August 26, 2006
Challenges of predicting treatment response in patients with rheumatoid arthritisJosef S Smolen, Daniel Aletaha
Nature Clinical Practice. Rheumatology|March 6, 2007
The health assessment questionnaire in routine clinical practiceDaniel Aletaha, Josef S Smolen
Clinical and Experimental Rheumatology|November 7, 2006
What should be our treatment goal in rheumatoid arthritis today?J S Smolen, D Aletaha
The New England Journal of Medicine|January 6, 2021
Trial of Upadacitinib or Abatacept in Rheumatoid ArthritisDavid Felson, Josef S Smolen
Annals of the Rheumatic Diseases|July 31, 2013
Biosimilars to treat inflammatory arthritis: the challenge of proving identityJonathan Kay, Josef S Smolen
Lupus|December 17, 2008
TNF inhibition in SLE: where do we stand?M Aringer, J S Smolen
Zeitschrift Fur Rheumatologie|January 22, 2009
[Treatment outcome parameters]G-R Burmester, J Smolen
Best Practice & Research. Clinical Rheumatology|August 7, 2007
The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical careDaniel Aletaha, Josef S Smolen
JAMA|February 6, 2019
Achieving Clinical Remission for Patients With Rheumatoid ArthritisDaniel Aletaha, Josef S Smolen
Pageof 173

Showing results (141-150 of 1,725) with videos related to

Sort By:
Pageof 173
Rheumatic Diseases Clinics of North America|March 1, 2006
The definition and measurement of disease modification in inflammatory rheumatic diseasesDaniel Aletaha, Josef S Smolen
Nature Clinical Practice. Rheumatology|August 26, 2006
Challenges of predicting treatment response in patients with rheumatoid arthritisJosef S Smolen, Daniel Aletaha
Nature Clinical Practice. Rheumatology|March 6, 2007
The health assessment questionnaire in routine clinical practiceDaniel Aletaha, Josef S Smolen
Clinical and Experimental Rheumatology|November 7, 2006
What should be our treatment goal in rheumatoid arthritis today?J S Smolen, D Aletaha
The New England Journal of Medicine|January 6, 2021
Trial of Upadacitinib or Abatacept in Rheumatoid ArthritisDavid Felson, Josef S Smolen
Annals of the Rheumatic Diseases|July 31, 2013
Biosimilars to treat inflammatory arthritis: the challenge of proving identityJonathan Kay, Josef S Smolen
Lupus|December 17, 2008
TNF inhibition in SLE: where do we stand?M Aringer, J S Smolen
Zeitschrift Fur Rheumatologie|January 22, 2009
[Treatment outcome parameters]G-R Burmester, J Smolen
Best Practice & Research. Clinical Rheumatology|August 7, 2007
The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical careDaniel Aletaha, Josef S Smolen
JAMA|February 6, 2019
Achieving Clinical Remission for Patients With Rheumatoid ArthritisDaniel Aletaha, Josef S Smolen
Pageof 173